Transurethral Resection of Prostate Syndrome

2

Review clinical trials related to Transurethral Resection of Prostate Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)

This study focuses on the treatment of benign prostatic hyperplasia which causes lower urinary tract symptoms. The purpose of the research project is to evaluate PAE in terms of both medical and health economic outcomes. To evaluate whether there are any differences in effect (IPSS), complications, costs and perceived quality of life compared with TUR-P.

Participants needed: 104
Trial details
Age: 45+Biological sex: MaleType: InterventionalSponsor: Uppsala UniversityUpdated: Oct 2, 2026Locations: 4
Eligibility criteria

Benign prostatic hyperplasia where medical treatment has not helped or for other... [+5]

known prostate or bladder cancer [+7]

Status: Recruiting

Artery Embolization vs Operation of Benign Prostate Hyperplasia

Aim of the study is to compare prostate artery embolization (PAE) to the established surgical treatment for patient acceptance, morbidity, complications, and the functional outcomes. To compare length of stay, hospital costs and time for recovery. 140 patients will be randomized to PAE or surgery. Patients should suffer from lower urinary tract symptoms (LUTS), be candidates for both treatments and willing to undergo both procedures. Before randomization computed tomography angiography of the pelvic arteries is done to select eligible patients. Magnetic resonance imaging of prostate rules out possible cancer. The PAE is done in the angio suite in the radiology department injecting small particles into the prostate arteries. The surgery is done in the operation room in the urology department according to established procedures. Clinical follow-up include clinical visit after 3 months, 1 and 5 years. Acute as well as long term complications will be recorded.

Participants needed: 140
Trial details
Biological sex: MaleType: InterventionalSponsor: Oslo University HospitalUpdated: Dec 27, 2023Locations: 1
Eligibility criteria

LUTS from Benign Prostate Hyperplasia (BPH) with moderate and severe IPSS score... [+4]

Urological disorders: evidence of clinically significant prostate cancer [as def... [+4]